Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
CJC-1295 is a synthetic peptide which acts as a growth hormone-releasing hormone analogue and affects GHRH receptors
Gin Yi Lee, MD
Poor blood sugar control can lead to damage in the kidneys over time, a condition known as diabetic nephropathy
As demand outpaces supply, shortages have been reported, particularly in Europe, where the European Medicines Agency (EMA) does not anticipate resolution until beyond 2024
Peptides discussed or offered may be used in an off-label or investigational capacity and are not necessarily approved by the U.S
US$ 29.46
US$ 20.90
US$ 26.07
US$ 27.79
US$ 29.17
US$ 28.60
US$ 25.34
US$ 25.75
